POLR2J1 inhibitors are a collection of compounds that can directly or indirectly impact the functionality of POLR2J1, a subunit of RNA polymerase II. These inhibitors target various aspects of transcription and related cellular processes, highlighting the intricate network of interactions in which POLR2J1 is involved. Direct inhibition of POLR2J1 is challenging due to its structural and functional complexity. However, α-Amanitin and Triptolide serve as potent examples of direct inhibitors, with α-Amanitin binding to RNA polymerase II and blocking RNA synthesis, and Triptolide modifying the RPB1 subunit. DRB and Actinomycin D also target the elongation phase of transcription, affecting the broader function of RNA polymerase II which includes POLR2J1. The indirect inhibitors, such as Flavopiridol Hydrochloride, Cordycepin, and Ixabepilone, highlight the interdependency of transcription with other cellular processes. Flavopiridol Hydrochloride inhibits CDK9, a key kinase in the transcription machinery, thereby affecting the phosphorylation state and activity of POLR2J1. Cordycepin causes premature termination of RNA, impacting the overall transcription process. Ixabepilone, while primarily a microtubule-stabilizing agent, provides insights into how changes in cellular dynamics can influence transcription.
Moreover, compounds like Rocaglamide, Burixafor, and PF 477736 underscore the connection between transcriptional regulation and broader signaling pathways. By modulating translational processes, signaling pathways, and cellular responses to DNA damage, these inhibitors can indirectly influence POLR2J1 activity. In summary, POLR2J1 inhibitors, encompassing a range of chemical entities, underscore the protein's pivotal role in transcription. These inhibitors provide valuable tools for studying the complex processes of gene expression and the functional dynamics of RNA polymerase II. They illustrate the intricate interplay between transcription machinery and various cellular pathways, offering insights into the regulation of gene expression at multiple levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A highly potent inhibitor of RNA polymerase II, it binds to the enzyme and prevents the elongation phase of RNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that inhibits the activity of RNA polymerase II by covalent modification of the RPB1 subunit, potentially affecting POLR2J1 function. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
An adenosine analog that selectively inhibits RNA polymerase II transcription elongation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase II by preventing the elongation step of transcription. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
A cyclin-dependent kinase inhibitor that can indirectly affect RNA polymerase II function by inhibiting CDK9, a component of the P-TEFb complex that phosphorylates POLR2J1. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Inhibits RNA synthesis by incorporating into RNA and inducing chain termination, potentially affecting POLR2J1-involved transcription. | ||||||
Rocaglamide | 84573-16-0 | sc-203241 sc-203241A sc-203241B sc-203241C sc-203241D | 100 µg 1 mg 5 mg 10 mg 25 mg | $275.00 $474.00 $1639.00 $2497.00 $5344.00 | 4 | |
Inhibits translation initiation and can indirectly influence POLR2J1 function by affecting upstream translational processes. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $115.00 $431.00 | ||
A checkpoint kinase inhibitor, indirectly affecting the cellular responses to DNA damage and potentially influencing POLR2J1 activity. | ||||||
KPT 330 | 1393477-72-9 | sc-489062 | 5 mg | $173.00 | ||
A selective inhibitor of nuclear export, it can alter the nuclear-cytoplasmic transport, indirectly affecting POLR2J1-mediated transcription. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits protein synthesis by interfering with the peptidyl transferase activity of the ribosome, potentially affecting cellular processes related to POLR2J1. | ||||||